Cannabis Strategic Ventures (NUGS) Stock Price & Analysis

Cannabis Strategic Ventures (NUGS) Healthcare & Pipeline Overview

Cannabis Strategic Ventures, operating in the U.S. cannabis market, focuses on cultivation and partnerships within the cannabis and ancillary sectors. The company's negative profit margin and OTC market listing highlight the risks and challenges it faces in a competitive industry.

What Is the Investment Thesis for NUGS?

Cannabis Strategic Ventures presents a speculative investment opportunity within the cannabis sector, characterized by high risk and potential reward. The company's negative profit margin of -87.3% and listing on the OTC market indicate significant financial challenges. The company's success hinges on its ability to achieve profitability through efficient cultivation, strategic partnerships, and expansion into new markets. Growth catalysts include potential changes in cannabis regulations and increased consumer demand. However, investors should be aware of the risks associated with investing in a small, unprofitable company in a volatile industry. The company's beta of -31.42 suggests an inverse correlation with the market, which could be a factor during market downturns.

Based on FMP financials and quantitative analysis

NUGS Key Highlights

Market capitalization of $2.62M indicates a micro-cap company with limited resources and higher volatility.

• Negative P/E ratio of -0.04 reflects the company's lack of profitability.
• Gross margin of 9.4% suggests challenges in cost management and pricing strategy.
• Profit margin of -87.3% highlights significant operational inefficiencies and financial strain.
• Beta of -31.42 indicates a negative correlation with the market, which may offer some downside protection but also limits upside potential.

Who Are NUGS's Competitors?

NUGS is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are NUGS's Key Strengths?

Cultivation expertise.

• Strategic partnerships.
• Focus on the cannabis market.
• Location in California.

What Are NUGS's Weaknesses?

Negative profitability.

• Limited financial resources.
• Small market capitalization.
• OTC market listing.

What Are the Key Risks for NUGS?

Financial-distress signal — its Altman Z-Score of -11.82 sits in the distress zone (elevated bankruptcy risk).

• Weak fundamentals — a Piotroski F-Score of 1/9 flags soft profitability, leverage or efficiency.
• Insider selling — insiders were net sellers of roughly $64.0B recently.
• Intense competition from larger, more established cannabis companies.
• Regulatory uncertainty and changes in cannabis laws could negatively impact the company's operations.
• Fluctuations in cannabis prices could affect revenue and profitability.
• Limited access to capital could hinder the company's growth plans.
• Negative profitability and financial strain could lead to bankruptcy.

What Are NUGS's Competitive Advantages?

• Proprietary cultivation techniques (if any).
• Strategic partnerships within the cannabis industry.
• Early mover advantage in specific markets (if any).

What Does NUGS Do?

Cannabis Strategic Ventures, based in Los Angeles, California, engages in the cultivation of marijuana products within the United States. The company operates in the cannabis and ancillary sectors, focusing on incubating, developing, and partnering with other businesses. Since its inception, Cannabis Strategic Ventures has aimed to capitalize on the growing cannabis market by establishing cultivation operations and forming strategic alliances. The company's activities include cultivating various strains of cannabis, developing cannabis-infused products, and exploring opportunities in related sectors such as cannabis technology and retail. Cannabis Strategic Ventures seeks to differentiate itself through quality cultivation practices and strategic partnerships, although it faces competition from larger, more established players in the cannabis industry. The company's geographic focus is primarily within the United States, targeting states with legalized cannabis markets. Its success depends on navigating the complex regulatory landscape and effectively executing its growth strategy in a rapidly evolving market.

What Products and Services Does NUGS Offer?

• Cultivates marijuana products in the United States.
• Incubates cannabis-related businesses.
• Develops cannabis-related products and services.
• Partners with companies in the cannabis sector.
• Operates in the cannabis and ancillary sectors.
• Aims to capitalize on the growing cannabis market.

How Does NUGS Make Money?

• Cultivation and sale of marijuana products.
• Incubation and development of cannabis-related businesses.
• Strategic partnerships within the cannabis industry.

What Industry Does NUGS Operate In?

Cannabis Strategic Ventures operates within the rapidly evolving cannabis industry, which is characterized by increasing legalization, growing consumer demand, and intense competition. However, the industry faces regulatory hurdles, including varying state laws and federal prohibition. Cannabis Strategic Ventures competes with other cannabis cultivators and producers, including AOLS, CBGI, FIORF, HCANF, and HSMD, some of whom have greater access to capital and established distribution networks. The company's success depends on its ability to navigate the complex regulatory landscape and differentiate itself in a crowded market.

Who Are NUGS's Key Customers?

• Consumers in states with legalized cannabis markets.
• Businesses in the cannabis and ancillary sectors.
• Partners seeking to expand their presence in the cannabis industry.

3 transactions · 1 purchases, 2 sales, 0 other transactions · 3 identified insiders · most recent available transactions. Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.

NUGS Valuation & Market Position

With a $2.62M market cap, Cannabis Strategic Ventures sits in the micro-cap segment of the market.

Return on equity for Cannabis Strategic Ventures stands at 102.4%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -77.0%, showing how much profit it generates from its asset base. A current ratio of 0.12 means current liabilities exceed short-term assets, a liquidity point worth watching.

Cannabis Strategic Ventures's Piotroski F-Score is 1/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -11.82 places it in the distress zone, a signal of elevated financial risk.

Company Profile

Cannabis Strategic Ventures operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Los Angeles, US. The company is led by CEO Simon Yu. NUGS has traded publicly since 2009.

NUGS Financials

NUGS Latest News

NUGS Analyst Consensus

NUGS MoonshotScore

Cannabis Strategic Ventures Healthcare Stock: Key Questions Answered

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources